These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8503263)

  • 41. Expression of NKG2D and CD107 in CD8(+) effector memory lymphocytes in Churg-Strauss syndrome.
    Boita M; Rolla G; Mallone R; Martinuzzi E; Heffler E; Circosta P; Elia AR; Cignetti A; Caillat-Zucman S; de Menthon M; Guida G
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S57-61. PubMed ID: 22640649
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peripheral neuropathy in Churg-Strauss syndrome associated with IgA-C3 deposits.
    O'Donovan CA; Keogan M; Staunton H; Browne O; Farrell MA
    Ann Neurol; 1992 Sep; 32(3):411. PubMed ID: 1329612
    [No Abstract]   [Full Text] [Related]  

  • 43. [The immunoreactivity studies of the idiopathic inflammatory myopathy over the past three years in our laboratory].
    Hiruma S; Ohtsuka K; Satou T; Furuta T; Kimura M; Hashimoto S
    Rinsho Byori; 1998 Feb; 46(2):168-75. PubMed ID: 9528342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy.
    Schmidt B; Toyka KV; Kiefer R; Full J; Hartung HP; Pollard J
    Muscle Nerve; 1996 Apr; 19(4):474-87. PubMed ID: 8622727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative analysis of endoneurial T-cells in human sural nerve biopsies.
    Cornblath DR; Griffin DE; Welch D; Griffin JW; McArthur JC
    J Neuroimmunol; 1990 Feb; 26(2):113-8. PubMed ID: 1688876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IgG and IgM rheumatoid factor levels parallel interleukin-6 during the vasculitic phase in a patient with Churg-Strauss syndrome.
    Yokoyama A; Kohno N; Fujino S; Inoue Y; Hiwada K
    Intern Med; 1995 Jul; 34(7):646-8. PubMed ID: 7496076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HLA-DR-expressing cells and T-lymphocytes in sural nerve biopsies.
    Schrøder HD; Olsson T; Solders G; Kristensson K; Link H
    Muscle Nerve; 1988 Aug; 11(8):864-70. PubMed ID: 3262825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Matrix metalloproteinases-9 and -2 in secondary vasculitic neuropathies.
    Renaud S; Erne B; Fuhr P; Said G; Lacroix C; Steck AJ; Leppert D
    Acta Neuropathol; 2003 Jan; 105(1):37-42. PubMed ID: 12471459
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms of tissue injury in vasculitic neuropathies.
    Satoi H; Oka N; Kawasaki T; Miyamoto K; Akiguchi I; Kimura J
    Neurology; 1998 Feb; 50(2):492-6. PubMed ID: 9484378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunolocalization and activation of transcription factor nuclear factor kappa B in dysimmune neuropathies and familial amyloidotic polyneuropathy.
    Mazzeo A; Aguennouz M; Messina C; Vita G
    Arch Neurol; 2004 Jul; 61(7):1097-102. PubMed ID: 15262741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HLA-DR expression in peripheral neuropathies: the role of Schwann cells, resident and hematogenous macrophages, and endoneurial fibroblasts.
    Sommer C; Schröder JM
    Acta Neuropathol; 1995; 89(1):63-71. PubMed ID: 7709733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T-cell-mediated epineurial vasculitis and humoral-mediated microangiopathy in cryoglobulinemic neuropathy.
    Bonetti B; Invernizzi F; Rizzuto N; Bonazzi ML; Zanusso GL; Chinaglia G; Monaco S
    J Neuroimmunol; 1997 Mar; 73(1-2):145-54. PubMed ID: 9058770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of the RAGE pathway: a general mechanism in the pathogenesis of polyneuropathies?
    Haslbeck KM; Neundörfer B; Schlötzer-Schrehardtt U; Bierhaus A; Schleicher E; Pauli E; Haslbeck M; Hecht M; Nawroth P; Heuss D
    Neurol Res; 2007 Jan; 29(1):103-10. PubMed ID: 17427284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cutaneous activation of rage in nonsystemic vasculitic and diabetic neuropathy.
    Bekircan-Kurt CE; Uçeyler N; Sommer C
    Muscle Nerve; 2014 Sep; 50(3):377-83. PubMed ID: 24395344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allograft inflammatory factor-1: a pathogenetic factor for vasculitic neuropathy.
    Broglio L; Erne B; Tolnay M; Schaeren-Wiemers N; Fuhr P; Steck AJ; Renaud S
    Muscle Nerve; 2008 Oct; 38(4):1272-9. PubMed ID: 18816612
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peripheral neuropathy in systemic lupus erythematosus: pathomorphological features and distribution pattern of matrix metalloproteinases.
    Mawrin C; Brunn A; Röcken C; Schröder JM
    Acta Neuropathol; 2003 Apr; 105(4):365-72. PubMed ID: 12624790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic Value of Sural Nerve Biopsy: Retrospective Analysis of Clinical Cases From 1981 to 2017.
    Prada V; Massucco S; Venturi C; Geroldi A; Bellone E; Mandich P; Minuto M; Varaldo E; Mancardi G; Grandis M; Schenone A
    Front Neurol; 2019; 10():1218. PubMed ID: 31824401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypoxia-inducible factor 1alpha may be a marker for vasculitic neuropathy.
    Oka N; Kawasaki T; Mizutani K; Sugiyama H; Akiguchi I
    Neuropathology; 2007 Dec; 27(6):509-15. PubMed ID: 18021370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Skin biopsy as an additional diagnostic tool in non-systemic vasculitic neuropathy.
    Uçeyler N; Devigili G; Toyka KV; Sommer C
    Acta Neuropathol; 2010 Jul; 120(1):109-16. PubMed ID: 20204385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Wide range of lineages of cells expressing nerve growth factor mRNA in the nerve lesions of patients with vasculitic neuropathy: an implication of endoneurial macrophage for nerve regeneration.
    Mitsuma N; Yamamoto M; Iijima M; Hattori N; Ito Y; Tanaka F; Sobue G
    Neuroscience; 2004; 129(1):109-17. PubMed ID: 15489034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.